Related Experiment Video
Updated: Jul 10, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
Interaction between the P1 protein of Mycoplasma pneumoniae and receptors on HEp-2 cells
M Drasbek1, G Christiansen1, K R Drasbek2
1Institute of Medical Microbiology and Immunology, Bartholin Building, University of Aarhus, DK-8000 Aarhus C, Denmark.
Abstract:
The human pathogen Mycoplasma pneumoniae can cause atypical pneumonia through adherence to epithelial cells in the respiratory tract. The major immunogenic protein, P1, participates in the attachment of the bacteria to the host cells. To investigate the adhesion properties of P1, a recombinant protein (rP1-II) covering amino acids 1107-1518 of the P1 protein was produced. This protein inhibited the adhesion of M. pneumoniae to human HEp-2 cells, as visualized in a competitive-binding assay using immunofluorescence microscopy. Previous studies have shown that mAbs that recognize two epitopes in this region of P1 also reduce M. pneumoniae adhesion. Therefore, peptides covering these epitopes, of 8 and 13 aa, respectively, were synthesized to further investigate the adhesion region. None of these synthetic peptides reduced the binding of M. pneumoniae to the receptors on the host cells. Instead, 10 overlapping synthetic peptides covering the whole of rP1-II were evaluated in the competitive-binding assay using immunofluorescence microscopy. A reduction in the number of M. pneumoniae microcolonies was seen, which was confirmed for five peptides using a POLARstar OPTIMA reader to measure fluorescence intensity. The number of M. pneumoniae microcolonies adhering to the host cells was significantly reduced by these five peptides. Further investigations showed that inhibiting peptide 7 (amino acids 1347-1396) of the major adhesin protein P1 bound directly to host receptors, suggesting that the observed M. pneumoniae-inhibiting peptides occupied HEp-2 receptors, which are otherwise available for P1-mediated M. pneumoniae adhesion.
Insights
Researchers identified specific peptides that block Mycoplasma pneumoniae (M. pneumoniae) from adhering to human respiratory cells. These M. pneumoniae inhibiting peptides target host cell receptors, offering a potential strategy against atypical pneumonia.
Area of Science:
- Microbiology
- Immunology
- Cell Biology
Background:
- Mycoplasma pneumoniae is a human pathogen causing atypical pneumonia by adhering to respiratory epithelial cells.
- The P1 protein is crucial for M. pneumoniae attachment to host cells and is a major immunogenic target.
Purpose of the Study:
- To investigate the adhesion properties of the P1 protein and identify specific regions or peptides involved in M. pneumoniae attachment.
- To explore the potential of inhibiting M. pneumoniae adhesion through blocking host cell receptors.
Main Methods:
- Production of a recombinant P1 protein fragment (rP1-II) and its evaluation in competitive-binding assays.
- Synthesis and testing of short peptides corresponding to known epitopes and overlapping regions of rP1-II.
- Utilizing immunofluorescence microscopy and fluorescence intensity measurements to quantify bacterial adhesion.
Main Results:
- A recombinant P1 protein fragment (rP1-II) inhibited M. pneumoniae adhesion to HEp-2 cells.
- While short epitope-specific peptides were ineffective, five overlapping synthetic peptides significantly reduced M. pneumoniae microcolony adhesion.
- Inhibiting peptide 7 was found to bind directly to host cell receptors, suggesting a mechanism of blocking bacterial attachment.
Conclusions:
- Specific synthetic peptides derived from the P1 protein can effectively inhibit M. pneumoniae adhesion to host cells.
- The identified M. pneumoniae-inhibiting peptides function by occupying host cell receptors, thereby preventing bacterial attachment.
- These findings highlight potential therapeutic targets for preventing or treating M. pneumoniae infections.
Related Concept Videos
Atypical Pneumonia
Coronavirus
Pneumonia II: Pathophysiology
Bacterial Meningitis II: Pathophysiology
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
